ASKLEPIOS BIOPHARMACEUTICAL
Asklepios BioPharmaceutical is a biotechnology company developing adeno-associated virus (AAV) gene therapies for genetic disorders and other rare diseases. It offers proprietary AAV technology, manufacturing capabilities, and a robust pipeline of in-house clinical programs for clients in the medical biopharmaceutical industry. Its pipeline includes clinical-stage programs in Pompe disease and congestive heart failure and a diverse preclinical portfolio of therapeutics targeting neuromuscular, C... NS, and other diseases, as well as out-licensed clinical indications for hemophilia and Duchenne muscular dystrophy. The company’s gene therapy platform includes Pro10, an industry-leading proprietary cell line manufacturing process, and an extensive AAV capsid, and promoter library. Asklepios BioPharmaceutical was founded in 2001 and is headquartered in Research Triangle Park, North Carolina.
ASKLEPIOS BIOPHARMACEUTICAL
Industry:
Biopharma Biotechnology Health Care Manufacturing Medical Medical Device
Founded:
2001-01-01
Address:
Chapel Hill, North Carolina, United States
Country:
United States
Website Url:
http://www.askbio.com
Total Employee:
501+
Status:
Active
Contact:
+1 (919) 561-6210
Total Funding:
241.76 M USD
Technology used in webpage:
Person Schema Gravatar Profiles U.S. Server Location WP Engine Getty Images
Similar Organizations
Avinger
Avinger is a medical device company engaged in developing catheter-based technologies and devices for treating vascular diseases.
Bolt Threads
Bolt is a materials company that invents and scales materials that put the planet on a path towards a better future.
Immunome
Immunome is a biotechnology company that specializes in immunotherapy, biotechnology, and antigen discovery.
JenaValve Technology
JenaValve is a medical device company focused on the design and development of innovative transcatheter heart valve solutions
Masimo
Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive patient monitoring products.
MediWound
MediWound is a biotechnology specialty company focused on developing, manufacturing and commercializing innovative wound care products.
NGM Biopharmaceuticals
NGM Biopharmaceuticals is a drug discovery company developing biotherapeutics for the gastrointestinal endocrine system.
ResMed
A global leader in digital health and connected medical devices, plus software solutions that support out-of-hospital care providers.
SHINE Medical Technologies
SHINE Medical Technologies manufactures and supplies medical tracers and cancer treatment elements.
Vaxart
Vaxart is a biotechnology company that develops vaccine technology for the treatment of infectious diseases.
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2020-04-22 | Brainvectis | Brainvectis acquired by Asklepios BioPharmaceutical | N/A |
| 2019-09-17 | RoverMed BioSciences | RoverMed BioSciences acquired by Asklepios BioPharmaceutical | N/A |
| 2019-08-13 | Synpromics Ltd | Synpromics Ltd acquired by Asklepios BioPharmaceutical | N/A |
Investors List
Scottish Enterprise
Scottish Enterprise investment in Grant - Asklepios BioPharmaceutical
Vida Ventures
Vida Ventures investment in Private Equity Round - Asklepios BioPharmaceutical
TPG Capital Asia
TPG Capital Asia investment in Private Equity Round - Asklepios BioPharmaceutical
Muscular Dystrophy Association
Muscular Dystrophy Association investment in Grant - Asklepios BioPharmaceutical
Muscular Dystrophy Association
Muscular Dystrophy Association investment in Grant - Asklepios BioPharmaceutical
Key Employee Changes
| Date | New article |
|---|---|
| 2024-04-09 | AskBio appoints new chief scientific officer |
Official Site Inspections
http://www.askbio.com Semrush global rank: 2.55 M Semrush visits lastest month: 7.23 K
- Host name: 172.99.75.43
- IP address: 172.99.75.43
- Location: San Antonio United States
- Latitude: 29.4963
- Longitude: -98.4004
- Metro Code: 641
- Timezone: America/Chicago
- Postal: 78218
More informations about "Asklepios BioPharmaceutical"
Updated AskBio Leadership Structure Reflects Strategic Focus
Oct 13, 2023 “This move ensures that we have the leadership required to build on our more than 20 years of groundbreaking discovery experience and become a high-performing delivery …See details»
Ask Bio - a Gene Therapy Company in RTP, North …
AskBio is headquartered in Research Triangle Park, North Carolina, a thriving biotechnology hub with nearly 600 life science companies. Research and development facilities are located in Philadelphia, Pennsylvania; Upper …See details»
AskBio Announces 15 Presentations at American Society of Gene …
1 day ago Research Triangle Park, N.C., May 08, 2025 (GLOBE NEWSWIRE) -- Three oral and 12 poster presentations demonstrate breadth and progress of AskBio’s gene therapy research …See details»
AskBio Inc. - LinkedIn
AskBio Inc. | 40,013 followers on LinkedIn. AskBio Inc., a wholly owned and independently operated subsidiary of Bayer AG, is a fully integrated gene therapy company dedicated to …See details»
AskBio Announces 15 Presentations at American Society of
17 hours ago Viralgen, founded in 2017 as a subsidiary of AskBio Inc. within the Bayer AG group, is a Contract Development and Manufacturing Organization (CDMO) specializing in the …See details»
AskBio - 2025 Company Profile, Funding & Competitors - Tracxn
Apr 25, 2025 AskBio is an acquired company based in Durham (United States), founded in 2001 by Sheila Mikhail and Jude Samulski. It operates as a Provider of gene and protein therapies …See details»
AskBio Company Profile | Management and Employees List
AskBio Profile and History. AskBio, is a fully integrated molecular medicine and technology company with operations around the globe. AskBio remains dedicated to the advancement of …See details»
Bayer Acquires Asklepios BioPharmaceutical to Broaden ... - TPG Inc.
Berlin, Germany and Research Triangle Park, N.C. – October 26, 2020 – Bayer AG and Asklepios BioPharmaceutical, Inc. (AskBio) today announced an agreement under which Bayer will …See details»
Sitting Down With… Sheila Mikhail, CEO and Co …
Jul 6, 2023 Sitting Down With… Sheila Mikhail, CEO and co-founder, AskBio; founder, Columbus Children’s Foundation. After featuring in The Medicine Maker Power List 2023, Mikhail shares her expertise as a lawyer, a leader, and a …See details»
Pioneers in Gene Therapy - Leadership Team - AskBio
The AskBio Team. The AskBio team is comprised of some of the most accomplished and experienced genetic researchers, clinicians and biopharmaceutical industry veterans. Our founders are pioneers in the field of …See details»
AskBio Receives FDA Regenerative Medicine Advanced Therapy …
Feb 19, 2025 Berlin, Germany, and Research Triangle Park, N.C., USA, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Not intended for UK Media Regenerative Medicine Advanced Therapy …See details»
Working at Asklepios BioPharmaceutical - Zippia
Mar 14, 2024 Organization Type. Private. Social Media. Asklepios BioPharmaceutical, Inc. (AskBio) is a privately held AAV gene therapy based company founded in 2001 to advance the …See details»
AskBio Announces Strategic Collaboration with ReCode ... - Bayer
Jan 9, 2023 AskBio’s gene therapy platform includes Pro10â„¢, an industry-leading proprietary cell line manufacturing process, and an extensive capsid and promoter library. With global …See details»
AskBio Announces 15 Presentations at American Society of Gene …
1 day ago Research Triangle Park, N.C.– MAY 8, 2025 – AskBio Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, will deliver …See details»
Bayer Acquires AskBio to Broaden Innovation Base in Cell and …
Oct 20, 2015 About AskBio Founded in 2001, Asklepios BioPharmaceutical, Inc. (AskBio) is a privately held, clinical-stage gene therapy company dedicated to improving the lives of children …See details»
AskBio Announces 15 Presentations at American Society of Gene …
17 hours ago Viralgen, founded in 2017 as a subsidiary of AskBio Inc. within the Bayer AG group, is a Contract Development and Manufacturing Organization (CDMO) specializing in the …See details»
Bayer buys cell & gene therapy firm AskBio for $4 billion
Oct 26, 2020 Bayer is making clear its ambitions in cell and gene therapy with a $4 billion acquisition of US biotech Asklepios BioPharmaceutical, also known as AskBio. AskBio’s …See details»
AskBio Receives FDA Regenerative Medicine Advanced Therapy …
Feb 19, 2025 AskBio Inc. a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, today announced that investigational gene therapy AB-1005 for the …See details»
Our Focus Areas for Genetic Research | AskBio
AskBio scientists were among the first to introduce gene therapies for various forms of muscular dystrophy. As the first for-profit organization to receive a grant from the Muscular Dystrophy …See details»
Inside the $4B AskBio deal, the third largest buyout ever for an NC ...
Oct 27, 2020 Bayer will own AskBio’s gene therapy platform, including a broad intellectual property portfolio and a contract development and manufacturing organization based on …See details»